Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Genpro Research names Mr. Salih Siam as Senior Director, Sales & Business Development

Genpro Research, a global provider of advanced data analytics, clinical biometrics services and automation solutions for pharma, biotech and device companies announced the appointment of Salih Siam as Senior Director of Sales & Business Development effective March 1st, 2021.


News provided by

Genpro Research Inc

Mar 12, 2021, 07:10 ET

Share this article

Share toX

Share this article

Share toX

Genpro Research names Salih Siam as Senior Director, Sales & Business Development
Genpro Research names Salih Siam as Senior Director, Sales & Business Development

WALTHAM, Mass., March 12, 2021 /PRNewswire-PRWeb/ -- Genpro Research, a global provider of advanced clinical data analytics & reporting services, clinical biometrics services and machine-learning technologies designed to accelerate scientific literature review and medical writing, today announced the appointment of Salih Siam as Senior Director of Sales & Business Development effective March 1st, 2021.

Mr. Siam joins us from the global biometrics CRO, Cytel, where he was director of business development – responsible for sales of biometrics services in Europe.

Genpro is poised for a significant growth phase, as AI and machine learning algorithms, begin to assume a more and more central role in the design and conduct of clinical studies as well as for other enabling functions like medical affairs, medical & scientific writing, epidemiology etc.

Post this

With Genpro Research, Mr. Siam will be assuming a leadership role in the company's global sales organization.

Speaking on behalf of the Board of Directors, Steve Herbert, CCO said, "Genpro is poised for a significant growth phase, as AI and machine learning algorithms, begin to assume a more and more central role in the design and conduct of clinical studies as well as for other enabling functions like medical affairs, medical & scientific writing, epidemiology etc. Adding an accomplished sales executive at this time adds the necessary energy and focus to Genpro's growth. Sal will take us to the next phase of Genpro's growth journey."

Mr. Siam holds an honours degree in Molecular Medicine from the University of Sussex and subsequently advanced his career in life sciences, sales and business development for a number of organizations. His successes have spanned the globe setting up sales and lead development organizations in USA/Europe, gaining and growing key biotechnology and pharmaceutical accounts in Europe.

Mr. Siam is intimately knowledgeable on market dynamics and procurement challenges and has a track record of successful account management and revenue growth.

"I am excited to be a part of this high-caliber team and to be able to have this opportunity to lead Genpro Research into this new era. Genpro's services business is on a solid growth path with delivery excellence being the secret ingredient. Also, with the current demands on the biopharmaceutical community to bring therapies to market safely and quickly, there is a huge opportunity to deploy existing tried-and-tested machine learning/NLP technology into established workflows in the entire clinical development process. This kind of change is inevitable and will bring about a state-change in the way scientific literature review and medical writing is carried out. These services and technologies are at the core of Genpro's competence, and I am delighted to be joining at this promising time." – Sal Siam

About Genpro Research

Headquartered in Waltham, USA near the center of Massachusetts biotechnology revolution, Genpro Research is a next-generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry. Genpro's tools use Artificial Intelligence, Machine Learning, and Natural Language Processing algorithms to enable automation of several processes supporting drug development pipelines and post launch activities. Genpro offers two digital platforms as part of its product offerings. Voody for Automated Medical Literature Review, scientific writing & Publications and MOSS for Clinical Data Visualization and Analytics. Voody, Genpro's flagship product, is world's first and only integrated platform powered by AI-ML algorithms that helps researchers, medical writers, and reviewers to handle the entire workflow of search, authoring, quality control and publishing literature reviews, manuscripts, and other documentation. MOSS, on the other hand, provides strong semantic search and automated data visualization capabilities and provides powerful data monitoring capabilities to clinical scientists, medical directors, and clinical development teams.
Genpro also provides advanced solutions in Biostatistics & Programming, Medical Writing, and Regulatory Submissions in an integrated fashion, as a strategic partner for sponsor companies.

Media Contact

Jithin Muraleedharan, Genpro Research Inc, +1 +17817905524, [email protected]

Twitter, Facebook

SOURCE Genpro Research Inc

Related Links

http://www.genproresearch.com/

Modal title

Genpro Research names Salih Siam as Senior Director, Sales & Business Development
Genpro Research names Salih Siam as Senior Director, Sales & Business Development
Genpro Research names Salih Siam as Senior Director, Sales & Business Development

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.